We are live on ! Find out more
CALC icon

CalciMedica
CALC

13 hedge funds and large institutions have $2.72M invested in CalciMedica in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

11.99% more ownership

Funds ownership: 0% → 11.99% (+12%)

Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
$377K
Puts
–
Net Calls
+$377K
Net Calls Change
+$377K

Top Buyers

1
O
OrbiMed
New York
+$1.3M
2
DM
Deerfield Management
New York
+$1.16M
3
BCM
BML Capital Management
Indiana
+$388K
4
First Manhattan
First Manhattan
New York
+$57.8K
5
MPM
Meritage Portfolio Management
Kansas
+$43.7K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$1.19M +$1.3M +297,380 New
DM
2
Deerfield Management
New York
$1.07M +$1.16M +265,657 New
BCM
3
BML Capital Management
Indiana
$356K +$388K +88,781 New
First Manhattan
4
First Manhattan
New York
$53K +$57.8K +13,226 New
MPM
5
Meritage Portfolio Management
Kansas
$40K +$43.7K +10,000 New
TRCT
6
Tower Research Capital (TRC)
New York
$7.55K +$8.23K +1,882 New
Morgan Stanley
7
Morgan Stanley
New York
$6.24K +$6.8K +1,556 New
NA
8
NewEdge Advisors
Louisiana
$285 +$310 +71 New
UBS Group
9
UBS Group
Switzerland
$56 +$61 +14 New
Wells Fargo
10
Wells Fargo
California
$56 +$61 +14 New
GI
11
Gradient Investments
Minnesota
$52 +$57 +13 New
Bank of America
12
Bank of America
North Carolina
$4 +$4 +1 New
CG
13
Cutler Group
California
– +$61 +14 New

CALC Hedge Fund Activity: Q2 2023 in Review

13 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q2 2023, worth a combined $2.72M.

Buyers outnumbered sellers: 13 funds opened new CALC positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $1.3M.

  • 13 institutional investors held CalciMedica (CALC) as of Q2 2023, up from 0 in Q1 2023.
  • Funds reported $2.72M of CalciMedica stock for Q2 2023.
  • 13 funds opened new CalciMedica positions in Q2 2023 and 0 closed out, a net change of +13 holders.
  • The largest CalciMedica buyer in Q2 2023 was OrbiMed, an estimated $1.3M added.

Based on aggregated 13F filings for Q2 2023.